Bnp Paribas Asset Management Holding S.A. Ascendis Pharma A/S Transaction History
Bnp Paribas Asset Management Holding S.A.
- $37.3 Billion
- Q1 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 330,153 shares of ASND stock, worth $56.4 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
330,153
Previous 316,580
4.29%
Holding current value
$56.4 Million
Previous $43.6 Million
18.06%
% of portfolio
0.14%
Previous 0.11%
Shares
6 transactions
Others Institutions Holding ASND
# of Institutions
270Shares Held
61.9MCall Options Held
151KPut Options Held
226K-
Ra Capital Management, L.P. Boston, MA10.3MShares$1.76 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$935 Million4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$891 Million13.16% of portfolio
-
Janus Henderson Group PLC London, X04.49MShares$766 Million0.4% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$727 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.53B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...